Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.00%
SPX
+0.52%
IXIC
+0.52%
FTSE
+0.72%
N225
+1.43%
AXJO
-0.43%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Signals

undefined Logo
NVAX
Novavax
23 days ago
Analysts think NVAX stock price could increase by 164%
-10.78%
📡️ Health Care
undefined Logo
NVAX
Novavax
about 1 month ago
NVAX has been in the news 375% more than usual
-10.83%
📡️ Health Care
undefined Logo
NVAX
Novavax
about 1 month ago
NVAX has been in the news 500% more than usual
-16.74%
📡️ Health Care
undefined Logo
NVAX
Novavax
about 2 months ago
NVAX beat EPS expectations by 306.89%
0.00%
📡️ Health Care
undefined Logo
NVAX
Novavax
about 2 months ago
NVAX has been in the news 1500% more than usual
11.96%
📡️ Health Care
undefined Logo
NVAX
Novavax
2 months ago
NVAX is now undervalued and could go up 614%
8.61%
📡️ Health Care
undefined Logo
NVAX
Novavax
3 months ago
NVAX is now undervalued and could go up 614%
7.36%
📡️ Health Care
undefined Logo
NVAX
Novavax
4 months ago
NVAX missed EPS expectations by 58.31%
0.00%
📡️ Health Care
undefined Logo
NVAX
Novavax
4 months ago
Analysts think NVAX stock price could increase by 152%
-27.15%
📡️ Health Care
undefined Logo
NVAX
Novavax
6 months ago
NVAX has been granted a new patent
8.85%
📡️ Health Care
undefined Logo
NVAX
Novavax
7 months ago
NVAX has been granted a new patent
-5.05%
📡️ Health Care
undefined Logo
NVAX
Novavax
8 months ago
NVAX has been in the news 643% more than usual
28.13%
📡️ Health Care
Join our newsletter to keep up to date with us!
Stocks
Health Care
nvax
Novavax
NVAX
-0.13 (-2.00%)
6.37
USD
At close at Jun 27, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials